5VB Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Nykode Therapeutics ASA

Watchlist Manager

Watchlist

Price: 0.1995 EUR Market Closed

Market Cap: €65.1m

N	Nykode Therapeutics ASA XBER:5VB	NO
C	China Communications Services Corp Ltd XHAM:CMW	CN
A	Atinum Investment Co Ltd KOSDAQ:021080	KR
M	Merchants & Marine Bancorp Inc OTC:MNMB	US
	GreenFirst Forest Products Inc F:IMT	CA
B	Blancco Technology Group PLC XBER:F2B	UK
O	Oriola Oyj F:O5O	FI
	Vulcan Minerals Inc F:VM3	CA

Profitability Summary

Nykode Therapeutics ASA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Low Operating Margin

Negative 3Y Average Operating Margin

-645%

Low Net Margin

Negative 3Y Average Net Margin

-410%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-894%

Negative ROE

-11%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-159%

ROIC is Increasing

-577% > -56%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.